Health
Pfizer vaccine may be less effective for obese people, study suggests – ConsumerAffairs
Obesity may weaken the efficacy of the Pfizer/BioNTech COVID-19 vaccine, new data suggests. A team of researchers in Rome found that obese people who h

Photo (c) Karl Tapales – Getty Images
Obesity may weaken the efficacy of the Pfizer/BioNTech COVID-19 vaccine, new data suggests.
A team of researchers in Rome found that obese people who had received two doses of the vaccine produced only about half the number of antibodies in response. The scientists defined obese as having a body mass index (BMI) over 30.
The study looked at the effect of the vaccine on 248 health care workers seven days after they had received their final dose. Among those…
-
Noosa News19 hours ago
Young voices shape Sunshine Coast’s future
-
Business19 hours ago
2 Low Cost Active ASX ETFs to consider
-
Noosa News16 hours ago
CopperString transmission line projected to cost almost $14b amid massive blowout
-
Noosa News18 hours ago
SXSW Sydney Has Announced the First 40 Speakers That’ll Be Taking to the Stage at Its 2025 Conference